Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.
about
Fatty acid metabolism and the basis of brown adipose tissue functionNeural control of energy balance: translating circuits to therapiesNext generation of weight management medications: implications for diabetes and CVD riskObesity: Current and potential pharmacotherapeutics and targets.New perspectives on the development of antiobesity drugs.Melanocortin-4 receptor modulators for the treatment of obesity: a patent analysis (2008-2014).Latest approaches for the treatment of obesity.Horizons in the Pharmacotherapy of Obesity.
P2860
Q26744147-1AC56C2C-903C-40DC-B945-D00B1D7E865AQ27005992-173BCBD1-C586-4B33-871E-6DEF9FD70C19Q28082858-2EB516EC-8936-45A8-8B40-6458EB89C9A5Q30243992-98527BC4-CDFD-403F-B113-07F328A8FB70Q38397340-BC8FFA37-3E9E-4F2B-9FB2-95EDD64C88EEQ38411478-F9188686-5BC2-4820-AE8A-31E7A6CED869Q38475978-0ACF0B4B-4CD3-4AFA-BC57-B5A525C9804DQ38582461-BA44EEFA-2E42-4152-B07C-A561B902368A
P2860
Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Investigational drugs in Phase ...... evelopment of novel therapies.
@en
type
label
Investigational drugs in Phase ...... evelopment of novel therapies.
@en
prefLabel
Investigational drugs in Phase ...... evelopment of novel therapies.
@en
P2093
P2860
P1476
Investigational drugs in Phase ...... evelopment of novel therapies.
@en
P2093
David A Price
Philip A Carpino
V Margaret Jackson
P2860
P304
P356
10.1517/13543784.2014.918952
P407
P577
2014-07-07T00:00:00Z